The growing incidence of infectious diseases, cancer, and chronic illnesses has substantially increased the demand for ...

The global Oligonucleotide Synthesis Market is valued at USD 7.78 Billion in 2024 and is projected to reach a value of USD 21 ...

Liquid-liquid phase separation (LLPS) has emerged as a major organizing principle in cells. Recent work showed that multiple components of integrin-mediated focal adhesions, including p130Cas can form ...

Ribosomes are tiny molecular machines inside all living cells that build proteins, and ribosome biogenesis is the complex, ...

The global mRNA vaccines and RNAi therapeutics market size was US$ 707.9 million in 2021. The global mRNA vaccines and RNAi therapeutics market size is estimated to reach US$ 8210.2 million by 2030, ...

A fungus that is thought to have claimed the lives of several excavators working on King Tutankhamun's burial site has had a ...

Ribosomes are tiny molecular machines inside all living cells that build proteins, and ribosome biogenesis is the complex, ...

Arsenale Bioyards recognized the inefficiencies and developed a platform that could radically change biomanufacturing, much like the Bessemer converter in the mid-19th century transformed the steel ...

As for what that means in the context of aesthetic treatments, she continues: “This is relevant in aesthetic practice as the ...

Based on several lines of interesting data, the authors conclude that FMRP, though associated with stalled ribosomes, does not determine the position on the mRNAs at which ribosomes stall. Although ...

The partners will use UNP's AI-based macrocycle discovery platform to develop synthetic peptide therapeutics for multiple disease targets.

AbbVie's $2.1 billion Capstan deal brings a novel in-vivo CAR-T therapy and tLNP platform to boost its immunology pipeline.